Roche Holding AG (OTCQX International Premier:RHHBF)

223.02
Delayed Data
As of May 24
 0.00 / 0.00%
Today’s Change
221.74
Today|||52-Week Range
277.46
-10.90%
Year-to-Date
Allergan Stock Down Since Q1 Earnings Report: Here's Why
May 23 / Zacks.com - Paid Partner Content
Exelixis' Cabometyx Gets EU Nod for First-Line Kidney Cancer
May 17 / Zacks.com - Paid Partner Content
Roche (RHHBY) Announces Positive Data on Hemophilia Drug
May 21 / Zacks.com - Paid Partner Content
Roche's Actemra Gets FDA Nod for Subcutaneous Formulation
May 15 / Zacks.com - Paid Partner Content
Roche Tecentriq Combo Achieves Longer Overall Survival Rate
May 17 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close223.02
Today’s open223.45
Day’s range223.02 - 223.45
Volume12
Average volume (3 months)157
Market cap$36.8B
Data as of 10:32am ET, 05/24/2018

Growth & Valuation

Earnings growth (last year)-9.88%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)+5.48%
P/E ratio17.1
Price/Sales4.01
Price/Book7.24

Competitors

No competitors data available.

Financials

Next reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$54.2B
Annual profit (last year)$8.8B
Net profit margin16.20%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chief Executive Officer &
Executive Director
Severin Schwan
Chief Financial &
Information Technology Officer
Alan Hippe
Corporate headquarters
Basel, Basel-stadt (basle Town)

Forecasts